A study by the Kasturba Medical College and tertiary care hospital said to be first of its kind from Karnataka, has found that Helicobacter pylori, a bacterium that resides in the human stomach and causes ulcers, gastritis and stomach cancers, has gained resistance to three commonly used antibiotics - metronidazole, levofloxacin and clarithromycin that the drugs may not be able to provide relief anymore.
This important finding was the result of the joint collaboration of KMC, MAHE Scientists and Scientists from Marshall Centre, the University of Western Australia. The KMC Scientists were: Dr Mamatha Ballal (Team Lead), Dr Vignesh Shetty, Dr Ganesh Pai, Dr Ramachandra L, Dr Shiran Shetty and the UWA Scientists: Dr Alfred Tay, Dr Eng Guan Chua and Binit Lamichhane.
The study was aimed to gain insight on the prevalence and mechanism of drug resistance in Helicobacter linked diseases so as to help develop strategies with more rational antibiotic combinations for treatment. This will also help implement precise therapy and thus prevent recurrence of the infections.
"The KMC team was a truly interdisciplinary team which put together expertise across disciplines to reach these findings. Dr Vignesh Shetty trained with a Nobel Laureate, Professor Barry Marshall. Using highly advanced methods and skills, what could have remained as a lab bench technique has been brought to the bedside for better patient care", said Dr Pragna Rao, Dean, KMC.
This study can act as a strong foundation to progress in national epidemiological surveillance which will be beneficial in evidence-based treatment and also as a managerial follow-up of eradication of Helicobacter if the first line treatment fails. The working group at KMC in future plans to come out with a rapid kit for detection of drug resistance in bacteria, which would help clinicians to modulate treatment regimen.
This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
